Five-year Angiographic Follow-up of the Bioabsorbable Vascular Solutions (BVS) Everolimus Eluting Coronary Stent System.
- Conditions
- Coronary artery disease10011082
- Registration Number
- NL-OMON36133
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 13
Inclusion Criteria
Previous inclusion in the *BVS Everolimus Eluting Coronary Stent System-First in Man (FIM) Clinical Investigation: Cohort A (05-370)*.
Signed Informed Consent
Exclusion Criteria
Left ventricular ejection fraction < 30%
Hypersensitivity or contra-indication to treatment with heparin or contrast that cannot be adequately pre-medicated
Renal insufficiency
Bleeding diathesis or coagulopathy
Stroke within the past year
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method